Zhejiang Provincial People's Hospital

This early-phase trial tests a new treatment called WTX-212C, which uses engineered red blood cells to target advanced solid tumors. About 24 adults who have run out of standard options will receive the drug intravenously. The main goal is to check safety and find the right dose,…

This phase 4 trial tests whether two traditional Chinese patent medicines, Xiaojin Pill and Neixiao Luoli Pill, can safely reduce the size of benign or low-risk thyroid nodules. 108 adults aged 18-65 will be randomly assigned to take one of the pills or receive only lifestyle adv…

This study tests a safe, non-invasive brain stimulation technique called tDCS to help people who have trouble swallowing after a stroke. About 76 adults who had a stroke 1 to 6 months ago will receive either real or fake stimulation over the cerebellum. Researchers will measure c…